Personalized Anaesthesia: Tailoring Drug Regimens Based on Genetics and Metabolism
Scientific and Innovative Therapy · 2025
DOI: 10.64582/ivit.uz.251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific and Innovative Therapy, 2025. Verfasst von Shavkatjon Bozorov und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Anaesthetic practice is evolving from population-based drug protocols toward precision medicine approaches that account for interindividual variability in drug response. Pharmacogenomics and metabolic profiling provide a scientific framework for optimizing anaesthetic drug regimens, thereby enhancing safety and efficacy in perioperative care. This article synthesizes evidence from forty Scopus-indexed studies published between 2015 and 2025, focusing on genetic polymorphisms, metabolic states, and computational innovations that underpin personalized anaesthesia. Notable genetic determinants include polymorphisms of CYP2D6, CYP2C19, CYP3A4, BCHE, and RYR1, each contributing to altered pharmacokinetics or risk of adverse reactions such as malignant hyperthermia and prolonged neuromuscular blockade. Metabolic comorbidities such as obesity, renal dysfunction, and diabetes further modulate drug clearance and distribution, underscoring the need for integrated multi-omics approaches. The methods employed for this review follow a structured search strategy across Scopus, PubMed, and related databases, identifying 40 high-quality studies relevant to anaesthetic pharmacogenomics and metabolism. Results are presented in the form of two comprehensive tables and figures illustrating gene–drug interactions and global variant frequencies. The discussion highlights clinical applications, the role of machine learning and decision-support systems, and the ethical, economic, and implementation barriers to personalized anaesthesia. It concludes that integration of genomic and metabolic profiling, supported by artificial intelligence, represents a paradigm shift in perioperative medicine. Future work must focus on standardization, cost-effectiveness, and equitable access to precision anaesthesia strategies worldwide.
Zitieren
APA
Bozorov, S., Haydarov, A., & Toshpulatova, G. (2025). Personalized Anaesthesia: Tailoring Drug Regimens Based on Genetics and Metabolism. Scientific and Innovative Therapy. https://doi.org/10.64582/ivit.uz.251
Vancouver
Bozorov S, Haydarov A, Toshpulatova G. Personalized Anaesthesia: Tailoring Drug Regimens Based on Genetics and Metabolism. Scientific and Innovative Therapy. 2025. doi:10.64582/ivit.uz.251
BibTeX
@article{Bozorov2025,
author = {Bozorov, Shavkatjon and Haydarov, Abdulhamid and Toshpulatova, Gavharshodbegim},
title = {Personalized Anaesthesia: Tailoring Drug Regimens Based on Genetics and Metabolism},
journal = {Scientific and Innovative Therapy},
year = {2025},
doi = {10.64582/ivit.uz.251}
}
EUVIMED